Amylyx Pharmaceuticals Etf Price History
| AMLX Etf | USD 3.28 0.22 7.19% |
If you're considering investing in Amylyx Etf, it is important to understand the factors that can impact its price. As of today, the current price of Amylyx Pharmaceuticals stands at 3.28, as last reported on the 26th of February, with the highest price reaching 3.28 and the lowest price hitting 3.06 during the day. Amylyx Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the etf had a -0.23 % return per unit of risk over the last 3 months. Amylyx Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amylyx Pharmaceuticals' Risk Adjusted Performance of (0.13), mean deviation of 3.3, and Standard Deviation of 4.09 to double-check the risk estimate we provide.
Amylyx Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
Amylyx |
Sharpe Ratio = -0.2279
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AMLX |
Estimated Market Risk
| 4.1 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.93 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Amylyx Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amylyx Pharmaceuticals by adding Amylyx Pharmaceuticals to a well-diversified portfolio.
Price Book 1.3386 | Enterprise Value Ebitda (11.71) | Price Sales 1.3345 | Shares Float 39.2 M | Wall Street Target Price 8 |
Amylyx Pharmaceuticals Etf Price History Chart
There are several ways to analyze Amylyx Pharmaceuticals Etf price data. The simplest method is using a basic Amylyx candlestick price chart, which shows Amylyx Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 27, 2024 | 5.74 |
| Lowest Price | February 24, 2025 | 3.0 |
Amylyx Pharmaceuticals February 26, 2025 Etf Price Synopsis
Various analyses of Amylyx Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Amylyx Etf. It can be used to describe the percentage change in the price of Amylyx Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Amylyx Etf.| Amylyx Pharmaceuticals Price Daily Balance Of Power | 1.00 | |
| Amylyx Pharmaceuticals Price Rate Of Daily Change | 1.07 | |
| Amylyx Pharmaceuticals Price Action Indicator | 0.22 |
Amylyx Pharmaceuticals February 26, 2025 Etf Price Analysis
Amylyx Etf Price History Data
The price series of Amylyx Pharmaceuticals for the period between Thu, Nov 28, 2024 and Wed, Feb 26, 2025 has a statistical range of 2.74 with a coefficient of variation of 18.41. The prices are distributed with arithmetic mean of 4.07. The median price for the last 90 days is 3.84. The company issued dividends on March 28, 2018.| Open | High | Low | Close | Volume | ||
02/26/2025 | 3.06 | 3.28 | 3.06 | 3.28 | ||
| 02/25/2025 | 2.98 | 3.14 | 2.87 | 3.06 | 718,798 | |
| 02/24/2025 | 3.40 | 3.40 | 2.99 | 3.00 | 936,675 | |
| 02/21/2025 | 3.52 | 3.58 | 3.28 | 3.30 | 492,207 | |
| 02/20/2025 | 3.49 | 3.65 | 3.44 | 3.52 | 497,478 | |
| 02/19/2025 | 3.52 | 3.63 | 3.42 | 3.52 | 437,594 | |
| 02/18/2025 | 3.78 | 3.88 | 3.52 | 3.56 | 666,978 | |
| 02/14/2025 | 3.61 | 3.74 | 3.54 | 3.72 | 374,326 | |
| 02/13/2025 | 3.59 | 3.69 | 3.51 | 3.59 | 330,924 | |
| 02/12/2025 | 3.32 | 3.59 | 3.30 | 3.53 | 654,172 | |
| 02/11/2025 | 3.71 | 3.75 | 3.39 | 3.40 | 656,562 | |
| 02/10/2025 | 3.83 | 3.95 | 3.64 | 3.74 | 848,538 | |
| 02/07/2025 | 3.76 | 3.96 | 3.74 | 3.80 | 658,189 | |
| 02/06/2025 | 3.70 | 3.83 | 3.67 | 3.75 | 815,612 | |
| 02/05/2025 | 3.62 | 3.90 | 3.62 | 3.69 | 1,581,986 | |
| 02/04/2025 | 3.43 | 3.71 | 3.36 | 3.62 | 1,003,179 | |
| 02/03/2025 | 3.54 | 3.66 | 3.41 | 3.42 | 846,575 | |
| 01/31/2025 | 3.51 | 3.75 | 3.47 | 3.65 | 1,392,069 | |
| 01/30/2025 | 3.52 | 3.61 | 3.42 | 3.51 | 401,954 | |
| 01/29/2025 | 3.44 | 3.62 | 3.39 | 3.46 | 504,267 | |
| 01/28/2025 | 3.46 | 3.53 | 3.21 | 3.45 | 1,216,097 | |
| 01/27/2025 | 3.60 | 3.66 | 3.45 | 3.49 | 783,587 | |
| 01/24/2025 | 3.56 | 3.65 | 3.45 | 3.60 | 805,994 | |
| 01/23/2025 | 3.47 | 3.58 | 3.31 | 3.56 | 557,699 | |
| 01/22/2025 | 3.40 | 3.51 | 3.24 | 3.48 | 810,663 | |
| 01/21/2025 | 3.43 | 3.48 | 3.11 | 3.45 | 3,200,006 | |
| 01/17/2025 | 3.56 | 3.67 | 3.43 | 3.60 | 886,150 | |
| 01/16/2025 | 3.34 | 3.53 | 3.30 | 3.50 | 1,256,226 | |
| 01/15/2025 | 3.24 | 3.39 | 3.11 | 3.37 | 1,150,903 | |
| 01/14/2025 | 3.10 | 3.23 | 3.02 | 3.13 | 1,161,806 | |
| 01/13/2025 | 3.48 | 3.48 | 3.10 | 3.18 | 1,364,544 | |
| 01/10/2025 | 3.72 | 3.79 | 3.44 | 3.50 | 1,618,089 | |
| 01/08/2025 | 3.85 | 3.85 | 3.65 | 3.77 | 289,522 | |
| 01/07/2025 | 3.91 | 3.99 | 3.77 | 3.84 | 398,100 | |
| 01/06/2025 | 4.10 | 4.17 | 3.91 | 3.92 | 489,575 | |
| 01/03/2025 | 3.99 | 4.18 | 3.93 | 4.15 | 440,494 | |
| 01/02/2025 | 3.79 | 4.05 | 3.77 | 3.91 | 527,893 | |
| 12/31/2024 | 3.86 | 3.95 | 3.71 | 3.78 | 690,931 | |
| 12/30/2024 | 3.83 | 3.92 | 3.73 | 3.84 | 562,580 | |
| 12/27/2024 | 4.01 | 4.08 | 3.76 | 3.87 | 680,335 | |
| 12/26/2024 | 3.94 | 4.15 | 3.92 | 4.07 | 679,240 | |
| 12/24/2024 | 4.09 | 4.10 | 3.96 | 4.00 | 221,148 | |
| 12/23/2024 | 4.03 | 4.13 | 3.99 | 4.07 | 478,895 | |
| 12/20/2024 | 3.98 | 4.18 | 3.96 | 4.05 | 550,924 | |
| 12/19/2024 | 3.94 | 4.11 | 3.78 | 3.96 | 2,229,575 | |
| 12/18/2024 | 4.26 | 4.31 | 3.94 | 3.94 | 579,470 | |
| 12/17/2024 | 4.19 | 4.40 | 4.19 | 4.28 | 704,056 | |
| 12/16/2024 | 4.08 | 4.28 | 4.00 | 4.18 | 762,037 | |
| 12/13/2024 | 4.37 | 4.49 | 4.10 | 4.12 | 674,636 | |
| 12/12/2024 | 4.39 | 4.64 | 4.35 | 4.41 | 648,339 | |
| 12/11/2024 | 4.45 | 4.50 | 4.32 | 4.37 | 968,288 | |
| 12/10/2024 | 4.94 | 5.04 | 4.45 | 4.51 | 1,305,204 | |
| 12/09/2024 | 5.14 | 5.15 | 4.87 | 4.88 | 690,064 | |
| 12/06/2024 | 5.06 | 5.19 | 4.96 | 5.14 | 481,436 | |
| 12/05/2024 | 5.26 | 5.26 | 4.93 | 4.97 | 768,550 | |
| 12/04/2024 | 5.37 | 5.50 | 5.24 | 5.26 | 655,825 | |
| 12/03/2024 | 5.52 | 5.52 | 5.22 | 5.35 | 685,939 | |
| 12/02/2024 | 5.51 | 5.62 | 5.45 | 5.55 | 431,968 | |
| 11/29/2024 | 5.70 | 5.79 | 5.51 | 5.54 | 414,816 | |
| 11/27/2024 | 5.47 | 5.85 | 5.32 | 5.74 | 617,777 | |
| 11/26/2024 | 5.80 | 5.80 | 5.35 | 5.45 | 714,143 |
About Amylyx Pharmaceuticals Etf history
Amylyx Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amylyx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amylyx Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amylyx Pharmaceuticals stock prices may prove useful in developing a viable investing in Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.
Amylyx Pharmaceuticals Quarterly Net Working Capital |
|
Amylyx Pharmaceuticals Etf Technical Analysis
Amylyx Pharmaceuticals technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Amylyx Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Amylyx Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Amylyx Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amylyx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.76) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.80) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.